Related Experiment Video
Updated: Jan 29, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Vascular Geometry Drives Stroke Risk in Sickle Cell Disease
Weiqiang Liu1, Christian Kassasseya2,3, Lazaros Papamanolis1,4
1Inria, Research Center Saclay Île-De-France, Palaiseau, France.
Insights
Sickle cell disease (SCD) stroke risk is linked to high blood flow velocity in brain arteries, not just anemia. In silico models show young SCD patients experience dangerous velocities due to vessel shape and flow, promoting cerebral vasculopathy.
Area of Science:
- Neurology
- Pediatrics
- Biomedical Engineering
Background:
- Sickle cell disease (SCD) is a primary cause of stroke in children and young adults.
- Cerebral vasculopathy (CV), linked to elevated intracranial arterial blood velocity, is a major contributor to SCD-related stroke.
- Understanding the hemodynamics of CV is crucial for predicting and preventing stroke in SCD patients.
Purpose of the Study:
- To investigate the relationship between hemoglobin levels and intracranial blood velocities in SCD patients.
- To identify factors beyond anemia that contribute to elevated blood velocity.
- To analyze flow anomalies and their role in CV progression.
Main Methods:
- Analysis of biological and transcranial Doppler data from pediatric and adult SCD patients.
- Development of an image-based in silico modeling approach to simulate blood flow.
- Simulation of blood flow in key cerebral arteries (internal carotid, anterior cerebral, middle cerebral) across different age groups.
Main Results:
- Anemia alone does not fully explain elevated velocities; no significant correlation was found in children under five.
- In silico models showed young SCD patients reach pathological velocities at physiological flow rates, unlike adults.
- Pathological velocities and complex flow patterns were observed in distal internal carotid arteries, correlating with stenosis development.
Conclusions:
- Hemodynamic factors like high flow rates, small arterial diameter, and vessel curvature significantly contribute to pathological velocities in young SCD patients.
- These hemodynamic forces likely cause endothelial damage, promoting CV progression and stroke risk.
- Findings support improved predictive models and early interventions for SCD-related stroke prevention.
Abstract:
Sickle cell disease (SCD) is the leading cause of stroke in children and young adults, primarily due to cerebral vasculopathy (CV) occurring within the first decade of life. The main risk factor for CV is elevated blood velocity in intracranial arteries, contributing to stenosis formation in very young children. This study addresses three key questions: (i) the relationship between hemoglobin levels and intracranial blood velocities in SCD patients, (ii) additional factors contributing to elevated velocity beyond anemia, and (iii) the presence of flow anomalies. To investigate these aspects, biological and transcranial Doppler data from pediatric and adult SCD patients were analyzed. An image-based in silico modeling approach was also developed to simulate blood flow in the internal carotid, anterior cerebral, and middle cerebral arteries of SCD patients, of different age classes, and prior to any possible stenosis. Analysis revealed that while anemia is a recognized CV risk factor, it does not fully explain elevated velocities, as no significant correlation was found in children under five. In in silico simulations, young patients reached pathological arterial intracranial velocities at physiological flow rates, whereas adults remained below risk thresholds even at high flow rates. Pathological velocities were primarily observed in distal internal carotid arteries, where stenoses often develop. High flow rates, small arterial diameters, and pronounced curvatures led to extreme velocities and complex flow, likely causing endothelial damage and promoting CV progression. These findings enhance understanding of hemodynamic mechanisms underlying SCD-related stroke risk, paving the way for improved predictive models and early interventions. Trial Registration: ClinicalTrials.gov identifier: NCT05199766.
Related Concept Videos
Coordination Number and Geometry
Predicting Molecular Geometry
Geometry of Hyperbolas
Energy to Drive Translocation
Generally, polypeptides are unfolded by two distinct...
Relative Risk
Molecular Geometry and Dipole Moments

